9:07 AM ET
8-K
Capital Raise
Lyell Immunopharma Capital Raise of $80M
Lyell Immunopharma entered into a securities purchase agreement to raise $80.0 million through a private placement of 7,428,040 shares of common stock. The shares were sold to institutional accredited investors at a price of $10.77 per share, with the company agreeing to file a resale registration statement within 30 days of closing.
- Value
- $80M
- Counterparty
- institutional accredited investors